To date, heterozygous mutations in two developmental transcription factor genes PITX2 and FOXC1 have been identified within ARS patients, accounting for 40 to 70% of cases [6, 7]. The gene discussed is PITX2; the disease is Axenfeld-Rieger syndrome.